InnovHeart rallies $55m Series C

InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised $55 million in Series C financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this